Mission Wealth Management’s Surface Oncology, Inc. Common Stock SURF Stock Holding History

Mission Wealth Management’s Portfolio SURF Stock Details SURF Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-10,000	Closed	-$16K	–	544
2022 Q2	$16K	Hold	10,000	–	–	﹤0.01%	508
2022 Q1	$29K	Hold	10,000	–	–	﹤0.01%	530
2021 Q4	$48K	Hold	10,000	–	–	﹤0.01%	532
2021 Q3	$76K	Hold	10,000	–	–	﹤0.01%	502
2021 Q2	$75K	Hold	10,000	–	–	﹤0.01%	485
2021 Q1	$78K	Hold	10,000	–	–	﹤0.01%	439
2020 Q4	$92K	Hold	10,000	–	–	0.01%	403
2020 Q3	$69K	Hold	10,000	–	–	0.01%	355
2020 Q2	$66K	Hold	10,000	–	–	0.01%	332
2020 Q1	$19K	Buy	+10,000	New	+$26.4K	﹤0.01%	294

Other funds holding SURF

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

AVAI

Atlas Venture Associates IX Boston, Massachusetts $11.8M AUM 58.35% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

DCM

DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Mission Wealth Management's SURF Position: Q3 2022 in Review

Mission Wealth Management sold out of Surface Oncology, Inc. Common Stock (SURF) in Q3 2022, closing a stake of 10,000 shares — an estimated $16K sold.

Mission Wealth Management first reported a position in SURF in Q1 2020 and held it in 10 quarters. The position peaked at $92K in Q4 2020. 79 funds tracked by Wall St. Rank hold SURF as of Q3 2022.

Mission Wealth Management reported no remaining Surface Oncology, Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
Mission Wealth Management sold 10,000 Surface Oncology, Inc. Common Stock shares in Q3 2022, an estimated $16K.
Mission Wealth Management first reported a position in Surface Oncology, Inc. Common Stock in Q1 2020 and held it in 10 quarters.
Mission Wealth Management's Surface Oncology, Inc. Common Stock position peaked at $92K in Q4 2020.
79 funds tracked by Wall St. Rank held Surface Oncology, Inc. Common Stock as of Q3 2022.

Based on Mission Wealth Management's 13F filing for Q3 2022, filed 12 Oct 2022.